ScienceAI imageCPHI Milan 2026 Highlights AI in Pharmaceutical Development
At CPHI Milan 2026, Andrew Parker, PhD, an executive drug development consultant at Quotient Sciences, explained how artificial intelligence is integrated into pharmaceutical development processes. The discussion focused on AI's role in improving drug bioavailability and accelerating development timelines, showcasing advances in technology within the pharmaceutical industry.
Pharmtech··Milan




